OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
4.190
-0.190 (-4.34%)
At close: Mar 20, 2026, 4:00 PM EDT
4.580
+0.390 (9.31%)
After-hours: Mar 20, 2026, 7:57 PM EDT

OnKure Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-59.52-52.67-35.31-51.96-39.77
Depreciation & Amortization
0.450.460.420.090.05
Stock-Based Compensation
11.634.530.24.323.89
Other Adjustments
0.390.520.14-0.770.65
Changes in Accounts Payable
-4.55-5.931.710.521.78
Changes in Other Operating Activities
-0.241.98-1.710.44-4.58
Operating Cash Flow
-51.83-51.12-34.55-47.36-37.98
Capital Expenditures
-0.05-0.05-0.25-0.35-0.2
Purchases of Investments
----101.6-31.41
Proceeds from Sale of Investments
-15.93-44.18.23
Investing Cash Flow
-0.0515.87-0.25-57.84-23.38
Long-Term Debt Issued
-5.86---
Net Long-Term Debt Issued (Repaid)
-5.86---
Issuance of Common Stock
0.254.580.070.4785.17
Net Common Stock Issued (Repurchased)
0.254.580.070.4785.17
Issuance of Preferred Stock
--53.06-47.24
Net Preferred Stock Issued (Repurchased)
--53.06-47.24
Other Financing Activities
-0.0455.69---
Financing Cash Flow
0.16116.1353.130.47132.41
Net Cash Flow
-51.7180.8918.33-104.7371.05
Free Cash Flow
-51.87-51.17-34.79-47.71-38.18
Free Cash Flow Per Share
-3.84-14.84-122.59-19.48-21.04
Levered Free Cash Flow
-63.9-50.36-35.13-51.25-42.72
Unlevered Free Cash Flow
-67.33-57.93-36.76-53.15-42.77
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q